S Alshabkhoun - Oak Park, Illinois 60304

S Alshabkhoun is categorized under Doctors in Oak Park, IL .

Business Name: S Alshabkhoun
Contact Person: Dr S Alshabkhoun
Address: 520 South Maple Avenue # 131, Oak Park, Illinois 60304
Phone Number: (708) 346-3060
Annual Revenue (USD): $100.000 to $499.999
Founding Year: 2000
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Doctors
SIC Code: 8011
NAICS Code: 621111
Share This Business:
Related Businesses: Cunningham Jennifer M MD - Oak Park, IL 60304
Fischer Ann B MD - Oak Park, IL 60304
Cobo Juan MD - Oak Park, IL 60304
Vein Care Center - Oak Park, IL 60304
Cole Brian J MD - Oak Park, IL 60304
Della Valle Craig MD - Oak Park, IL 60304
Noonan Daniel J MD - Oak Park, IL 60304
Cheung Jessie S MD - Oak Park, IL 60304
Srivastava Alka S MD - Oak Park, IL 60304
Merrill Pauline T MD - Oak Park, IL 60304
Mc Ginness Catherine MD - Oak Park, IL 60304
Weiss David J MD - Oak Park, IL 60304
Atluri Indira MD - Oak Park, IL 60304
Klugman Vanessa A MD - Oak Park, IL 60304
D'Alfonso Nausica MD - Oak Park, IL 60304
Slobodkin David MD - Oak Park, IL 60304
Shah Sejal MD - Oak Park, IL 60304
Humowiecki Stephen R MD - Oak Park, IL 60304
Aguinaldo Maria F MD - Oak Park, IL 60304
Hansberry Maria R MD - Oak Park, IL 60304

The company S Alshabkhoun provides B2C services in the form of Doctors from its single location in Illinois. 1 to 4 employees work for S Alshabkhoun, and the business now earns $100.000 to $499.999 per annum.

S Alshabkhoun was launched in 2000 and is classified under SIC code and category 8011 , and NAICS number and grouping 621111 . To contact S Alshabkhoun, please call Dr S Alshabkhoun with the phone number (708) 346-3060 or visit its single location at 520 South Maple Avenue # 131 in Oak Park, Illinois 60304.

The location of the single location can also be found using the coordinates 41.879294,-87.803643. Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.